Detalhe da pesquisa
1.
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.
Cancer
; 124(22): 4342-4349, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395359
2.
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
Biol Blood Marrow Transplant
; 23(6): 922-929, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267593
3.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
J Natl Compr Canc Netw
; 14(4): 389-400, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059188
4.
New cancers after autotransplantations for multiple myeloma.
Biol Blood Marrow Transplant
; 21(4): 738-45, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25555448
5.
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 13(11): 1398-435, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553768
6.
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.
Biol Blood Marrow Transplant
; 20(12): 2072-5, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25079874
7.
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Biol Blood Marrow Transplant
; 20(3): 402-408.e1, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24342394
8.
Older patients with myeloma derive similar benefit from autologous transplantation.
Biol Blood Marrow Transplant
; 20(11): 1796-803, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046833
9.
Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma.
Biol Blood Marrow Transplant
; 19(2): 260-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23073267
10.
Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study.
Br J Haematol
; 160(2): 199-206, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151215
11.
Multiple myeloma, version 1.2013.
J Natl Compr Canc Netw
; 11(1): 11-7, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307977
12.
Identifying monoclonal gammopathy of undetermined significance from electronic health records.
Cancer Rep (Hoboken)
; 6(3): e1755, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464325
13.
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 18(3): 486-92, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198542
14.
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.
Blood
; 115(5): 1098-105, 2010 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965688
15.
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.
J Natl Compr Canc Netw
; 10(10): 1211-9, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054875
16.
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study.
Br J Haematol
; 153(6): 729-40, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21534941
17.
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation.
Bone Marrow Transplant
; 55(9): 1810-1816, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286506
18.
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
Blood Cancer J
; 9(2): 17, 2019 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30718503
19.
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.
Clin Cancer Res
; 24(1): 106-119, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061640
20.
A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.
Leuk Lymphoma
; 55(1): 201-3, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23573824